GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (HKSE:02552) » Definitions » Inventories, Other

Hua Medicine (HKSE:02552) Inventories, Other : HK$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Hua Medicine's other inventories for the quarter that ended in Dec. 2023 was HK$0.00 Mil.

Hua Medicine's quarterly other inventories increased from Dec. 2022 (HK$0.00 Mil) to Jun. 2023 (HK$18.47 Mil) but then declined from Jun. 2023 (HK$18.47 Mil) to Dec. 2023 (HK$0.00 Mil).

Hua Medicine's annual other inventories stayed the same from Dec. 2021 (HK$0.00 Mil) to Dec. 2022 (HK$0.00 Mil) but then increased from Dec. 2022 (HK$0.00 Mil) to Dec. 2023 (HK$0.00 Mil).

Hua Medicine Inventories, Other Historical Data

The historical data trend for Hua Medicine's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Inventories, Other Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial - - - - -

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 18.47 -

Hua Medicine Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Hua Medicine (HKSE:02552) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (HKSE:02552) » Definitions » Inventories, Other
Comparable Companies
HKSE:01061 HKSE:02348 HKSE:02633 HKSE:06896 HKSE:01652 HKSE:03737 HKSE:02161 HKSE:00950 HKSE:08049 HKSE:00503 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Website
https://www.huamedicine.com
Hua Medicine is an investment holding company. It is engaged in development and commercialization of a global first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC. Some of its products are Dorzagliatin + Metformin, Dorzagliatin, Dorzagliatin + Pioglitazone and mGLUR5 NAM, among others.

Hua Medicine (HKSE:02552) Headlines

No Headlines